Manufacturers & marketing cos face logistical bottleneck following NPPA’s order on TMR of cancer drugs: Peethaambaran Kunnathoor, Chennai Monday, October 26, 2026, 08:00 Hrs [IS ...
India's diversity in genetics is a scientific advantage in clinical research: Dr Seema Pai: Nandita Vijayasimha, Bengaluru Monday, October 26, 2026, 08:00 Hrs [IST] India’s dive ...
CDSCO acts on registration of one more Ethics Committee for violation of NDCT Rules: Gireesh Babu, New Delhi Monday, October 26, 2026, 08:00 Hrs [IST] The Central Drugs Standard C ...
Maharashtra leads bulk drug PLI scheme with 19,180 MT capacity across five projects: Shardul Nautiyal, Mumbai Monday, October 26, 2026, 08:00 Hrs [IST] Maharashtra has recorded an ...
The Jan Aushadhi Kendras (JAKs) under the flagship scheme of Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP) run by the Department of Pharmaceuticals (DoP), has reported a growth of 8% in sales ...
Messe Muenchen India, a subsidiary of Messe München GmbH and a leading organiser of B2B trade fairs in India, has acquired PharmaTech Expo from PharmaTechnologyindex.com Pvt Ltd. (A Division of KNS ...
Global pharma major Lupin Limited announced the appointment of Brian Savage as president, chief legal officer. Brian will lead Lupin’s global Legal, Compliance, and Intellectual Property Management ...
Supriya Lifescience joint MD Shivani Wagh featured on Avendus Wealth–Hurun India U35 List 2026: Our Bureau, Mumbai Saturday, October 24, 2026, 11:30 Hrs [IST] Supriya Lifescienc ...
Prognica Labs and Pinnacology enter co-development and commercialization partnership to advance novel intranasal anxiety therapy: Dubai, UAE Saturday, October 24, 2026, 09:00 Hrs ...
Merck & Moderna to present positive results from phase 3 INTerpath-001 trial for intismeran autogene plus Keytruda at ESMO 2026 Presidential Symposium: Rahway, New Jersey Saturday ...
Labcorp, US FDA and Charles River announce research collaboration to advance preclinical methods for evaluating drug abuse potential: Burlington, North Carolina Saturday, October ...
Otsuka presents final phase 3 VISIONARY results at ASN demonstrating Voyxact stabilized kidney function and reduced risk of disease progression and kidney failure: Princeton, New ...